HOME >> BIOLOGY >> NEWS
Molecular clue to Alzheimer's mystery found

In cell biology studies, researchers report "strong evidence" that a molecule called ubiquilin controls levels of certain proteins that are central to the early development of Alzheimer's disease.

In today's Journal of Cell Biology, researchers of the University of Maryland Biotechnology Institute (UMBI) say the discovery may provide an important way to control the activity of proteins called presenilins. Previous studies showed that mutations in genes coding for presenilins cause early onset of Alzheimer's disease.

Mervyn Monteiro, research professor with UMBI's Medical Biotechnology Institute and coworkers at Case Western Reserve University, also found ubiquilin to be "highly expressed" in neurons of human brain and associated with tangles and plaques in neurons of brains that are afflicted with Alzheimer's and Parkinson's diseases, respectively.

"Ubiquilin is the first molecule, to our knowledge, that has been found to increase presenilin levels in cells," said Monteiro. "Now, we want to see how ubiquilin regulates presenilin proteins carrying Alzheimer's disease mutations. This is an important step in understanding presenilins and may lead to eventual treatments or cures for the neuropathological diseases."

Molecular genetic studies previously linked early-onset Alzheimer's disease to mutations in three genes: amyloid precursor protein, presenilin-1 and presenilin-2. However, the biological reasons why mutations in the genes cause Alzheimer's disease has not yet been fully resolved, said Monteiro. To find the latest clues, the researchers used combinations of immunological and DNA-taging methods to learn that ubiquilin is localized in both the nucleus and cytoplasm in cells.

The journal paper further explains that "modulation of presenilin levels by ubiquilin" may have important consequences to many cellular functions, because presenilins have been linked to various biological processes, including calcium regulation, apoptosis (pr
'"/>

Contact: Steve Berberich
berberic@umbi.umd.edu
410-385-6315
University of Maryland Biotechnology Institute
12-Nov-2000


Page: 1 2

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular marker predicts success of breast cancer treatment
10. Molecular image of genotoxin reveals how bacteria damage human DNA
11. Molecular mechanism found that may improve ability of stem cells to fight disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been ... Medical Neoasis™ active noise control device to attenuate typical noises in a simulated ... attenuated the alarm sounds from patient monitors, ventilators and other bedside devices that ...
(Date:7/2/2020)... ... July 01, 2020 , ... ... phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute ... Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... ... August 29, 2020 , ... ... manufacturing capability in Wuxi, China. The new plant operation will provide the local ... advanced technology. , “This facility will improve the flexibility of our offerings ...
(Date:8/12/2020)... ... August 12, 2020 , ... ... (EMMA International), a global leader in FDA compliance consulting has been named on ... private companies. The list represents a unique look at the most successful companies ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the leader in ... “BUILDING FOR LIFE.” The adoption of this taglines comes at a time of ... capacity to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. ...
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory ... 16 countries, has reached its 20th anniversary of worldwide use. Introduced in the ... top universities including University of Pennsylvania, University of Michigan, University of Maryland, University ...
Breaking Biology Technology:
Cached News: